Does glucosamine and chondroitin supplements affect kidneys?
Reading File
Searching PubMed
glucosamine chondroitin kidney renal function
Searching the Web
glucosamine chondroitin supplements kidney renal effects safety
Finding Sources
Searching PubMed
glucosamine kidney nephrotoxicity renal impairment
Reading File
Reading Article
PMID: 37571255
Here is a thorough, evidence-based answer on how glucosamine and chondroitin supplements may affect the kidneys:
Glucosamine & Chondroitin: Effects on Kidney Function
General Safety Profile
For healthy individuals, glucosamine and chondroitin are broadly considered safe at standard doses (glucosamine sulfate 500 mg + chondroitin sulfate 400 mg, three times daily), and short-to-medium-term use does not appear to cause significant kidney damage in most people. This dose regimen is the one most studied in osteoarthritis clinical trials (Swanson's Family Medicine Review).
What the Evidence Actually Shows
1. Mendelian Randomization Study (2023 - strongest causal evidence available)
A 2023 Mendelian randomization study published in Nutrients - a design that uses genetic variants to infer causality - found:
- Glucosamine: Genetically predicted intake was causally associated with a lower eGFR (beta = -0.240%, p = 6 × 10⁻¹²). This is a statistically robust signal.
- Chondroitin: Also associated with a lower eGFR (beta = -0.113%, p = 2 × 10⁻⁴).
- By contrast, vitamin/mineral supplements were associated with a higher eGFR, suggesting the effect is specific to these compounds.
This is the most rigorous study to date suggesting a potential causal reduction in kidney function with these supplements. The effect sizes are small, but the statistical significance is high.
2. Acute Interstitial Nephritis (Case Reports)
Rare case reports document acute interstitial nephritis following glucosamine use, particularly with more than 2 years of continuous use. This is an immune-mediated kidney injury, not simple toxicity.
3. Renal Excretion & Metabolic Burden
- Glucosamine is metabolized primarily in the liver, but certain forms require renal excretion, which may place added strain on kidneys during long-term supplementation.
- Chondroitin sulfate can be incorporated into small leucine-rich proteoglycans (SLRPs) like biglycan, which has pro-inflammatory properties and may impact fibrolytic renal diseases.
Who Should Be Most Cautious?
| Population | Risk Level | Recommendation |
|---|---|---|
| Healthy adults, short-term use | Low | Generally safe; no strong evidence of harm |
| Chronic kidney disease (CKD, any stage) | Higher | Consult nephrologist before use; limited safety data |
| Diabetic patients with nephropathy | Higher | Avoid or monitor - NSAIDs AND glucosamine may worsen kidney progression |
| Long-term users (>2 years) | Moderate | Periodic renal function monitoring advisable |
| Patients on warfarin | Moderate | Glucosamine increases INR; MHRA has issued warnings |
Key Takeaways
- No definitive harm in healthy kidneys at standard doses - but this is reassuring only up to a point.
- A 2023 Mendelian randomization study provides the strongest evidence yet that both glucosamine and chondroitin are causally linked to modestly reduced eGFR - meaning kidney function may decline slightly with regular use.
- CKD patients should avoid or use these supplements only under medical supervision.
- Long-term users should have periodic serum creatinine/eGFR checks.
- UK's NICE guidance (NG226) already advises against recommending glucosamine or chondroitin for osteoarthritis, partly due to uncertain benefit-risk balance.
Bottom line: These supplements are not acutely toxic to kidneys in most people, but the best available genetic evidence suggests they may gradually reduce kidney function over time - making them a meaningful concern for anyone with pre-existing renal disease or long-term supplementation habits. If you use them, periodic kidney function tests are a prudent precaution.
This is a shared conversation. Sign in to Orris to start your own chat.